Have a personal or library account? Click to login
Identification of new process-related impurity in the key intermediate in the synthesis of TCV-116 Cover

Identification of new process-related impurity in the key intermediate in the synthesis of TCV-116

Acta Pharmaceutica
Volume 69 (2019): Issue 1 (March 2019)
By: Ana Testen,  Miha Plevnik,  Bogdan Štefane and  Irena Kralj Cigić  
Open Access
|Dec 2018

Authors

Ana Testen

Faculty of Chemistry and Chemical Technology, University of Ljubljana, Slovenia
Novo Mesto, Slovenia

Miha Plevnik

Novo Mesto, Slovenia

Bogdan Štefane

Faculty of Chemistry and Chemical Technology, University of Ljubljana, Slovenia

Irena Kralj Cigić

irena.kralj-cigic@fkkt.uni-lj.si

Faculty of Chemistry and Chemical Technology, University of Ljubljana, Slovenia
DOI: https://doi.org/10.2478/acph-2019-0006 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 63 - 74
Accepted on: Sep 9, 2018
Published on: Dec 7, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
candesartan cilexetil (TCV-116),
diastereoisomers,
synthesis,
impurity,
HRMS
Related subjects:
Pharmacy,
Pharmacy, other

© 2018 Ana Testen, Miha Plevnik, Bogdan Štefane, Irena Kralj Cigić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 69 (2019): Issue 1 (March 2019)Next article